MS324 EXTENDED RELEASE NIACIN/LAROPIPRANT IS PROJECTED TO REDUCE CORONARY RISK BEYOND STATINS: COST-EFFECTIVENESS ANALYSIS IN SECONDARY PREVENTION PATIENTS IN GERMANY

✍ Scribed by Michailov, G.V.; Davies, G.M.; Ambegaonkar, B.M.; Krobot, K.J.

• Book ID: 118638826
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 55 KB
• Volume: 11
• Category: Article
• ISSN: 1567-5688
• DOI: 10.1016/s1567-5688(10)70825-4